| Q3 FY26 Earnings Conference Call
Summary : Manorama Industries demonstrates strong growth, driven by strategic capacity expansion and a focus on high-margin specialty fats and butters for global food and cosmetic industries.
Management Perspective positive : I am extraordinarily pleased to share that we continue to sustain our growth momentum.This revision underscores our confidence in our growth trajectory and the strength of our business model.We are very confident in our ability to sustain our growth momentum and achieve our revenue guidance.With prudently planned capex, we aim to strengthen our leadership in specialty fats and butter.
Concall Report Analysis & Insights
Business Overview
- Operates in a structurally undersupplied, high-growth exotic niche specialty fats and butters market.
- Leverages a backward integrated model with high-tech R&D and deep sourcing network.
- Serves key customers in chocolate, confectionery, and cosmetic sectors worldwide.
- Focuses on value-added products like cocoa butter equivalents and specialty fats.
- Committed to operational excellence and disciplined cost control measures.
Future Growth Prospects
- Revised FY26 revenue guidance upward from INR 1,150 crores to INR 1,300 crores.
- Plans to boost existing fractionation capacity by 30% to 52,000 MTPA by FY26.
- Committing INR 460 crores capex over 2-3 years for new facilities in India and West Africa.
- Projects include 75,000 MTPA cocoa butter alternatives, 75,000 MTPA fractionation, 90,000 MTPA refinery.
- Backward integration to a 90,000 MTPA processing factory in Burkina Faso, West Africa.
Management Insights
- Expressed gratitude to investors for their trust and faith in the company's long-term vision.
- Pleased with sustained growth momentum, reporting 73.3% year-on-year revenue growth.
- Attributed strong performance to enhanced value-added product mix and optimized facility utilization.
- Confident in sustaining growth momentum and achieving revised revenue guidance.
- Strives to be the preferred global supplier of specialty fats and butters through R&D and capacity expansion.
Signs of Skepticism
- Gross margin fluctuation (44.3% vs 52.8% last quarter) despite management stating it's 'range bound'.
- Analyst noted 500-day working capital cycle in March '25, management cited 120 days currently.
- Lack of specific details on how new projects will impact margins beyond 'sustainable level' or 'better level'.
Risk Factors
- Management acknowledges general business risks, but no specific, detailed risks were outlined.
- Raw material price fluctuations can impact gross margins, though EBITDA margins are stable.
- Large capital expenditure projects carry inherent execution and integration risks.
- Working capital management needs continuous optimization for new projects.
Good To Know
- Acquired 19.40 acres of new land adjacent to existing facility.
- Successfully commissioned a new packing plant and laboratory building, funded by internal accruals.
- Company holds numerous international certifications including FSSC 22000, ISO, RSPO, HALAL, ORGANIC.
- Recognized as a Government of India Star Export House.
Key Drivers
- Strong revenue growth, 73.3% Y-o-Y.
- Upwardly revised FY26 revenue guidance.
- Significant capacity expansion plans underway.
- Increasing share of high-margin value-added products.
Key Analyst Discussions
Competitive Environment
- Products are technology and formulation-driven, not commodity-linked, ensuring stable pricing.
- Customer relations are application-specific, leading to long-term client retention.
- Niche technical product manufacturing differentiates from commodity businesses.
- Backward integration provides control over quality, cost, and supply stability.
Market Trends & Consumer Behavior
- Steady demand from chocolate, confectionery, and cosmetic sectors globally.
- Significant demand-supply gap exists for niche specialty products.
- EU deforestation rules primarily pertain to cocoa, not company's raw materials.
Financial Highlights
- 9M FY26 revenue: INR 975 crores, 81.3% Y-o-Y growth (65% volume, 15-16% price).
- Q3 FY26 revenue: INR 363 crores, 73.3% Y-o-Y growth.
- 9M FY26 EBITDA: INR 265 crores (27.2% margin); Q3 FY26 EBITDA: INR 98 crores (27.1% margin).
- Working capital cycle reduced to 120 days from 150-160 days (H1).
- Other income jump in Q3 due to forex gain on import side.
Product Composition
- Value-added products contribute around 75% of sales, aiming for 85-95%.
- ESOS (enzymatic stearin-oleic-stearic) converts soft fractions to hard fats for food applications.
- New projects will increase production of stearin-based fats and cocoa butter equivalents.
- Diversifying raw material base to support new product lines.
Strategic Considerations
- INR 460 crores capex funded primarily by internal accruals, with INR 52 crores already spent.
- Capex projects include new CBA, fractionation, refinery, and West Africa processing facilities.
- Dekel partnership in Brazil has started contributing minor revenue.
- New capacities expected to be fully commercialized by FY28, phased over 2-3 years.